• 1
    Woods NS, Marlow N, Costeloe K, Gibson AT, Wilkinsin AR. Neurologic and development disability after extremely preterm birth. EPICure Study Group. N Engl J Med 2000;343:37884.
  • 2
    Lettieri L, Vintzileos AM, Rodis JF, Albini SM, Salafia CM. Does “idiopathic” preterm labour resulting in preterm birth exist? Am J Obstet Gynecol 1993;168:14805.
  • 3
    Seo K, McGregor JA, French JI. Preterm birth is associated with increased risk of maternal and neonatal infection. Obstet Gynecol 1992;79:7580.
  • 4
    Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract as a marker for subsequent preterm delivery and late miscarriage. BMJ 1994;308:2958.
  • 5
    Leitich H, Kaider A. Fetal fibronectin—how useful is it in the prediction of preterm birth? BJOG 2003;110(Suppl 20):6670.
  • 6
    Hoesli I, Tercanli S, Holzgreve W. Cervical length assessment by ultrasound as a predictor of preterm labour—is there a role for routine screening? BJOG 2003;110(Suppl 20):615.
  • 7
    Goffinet F. Primary predictors of preterm labour. BJOG 2005;112(Suppl 1):3847.
  • 8
    Romero R, Espinoza J, Gotsch F, Kusanovic JP, Friel L, Erez O, et al. The use of high-dimensional biology techniques (genomics, transcriptomics, proteomics, and metabolomics) to understand complex diseases in obstetrics. BJOG 2006;113(Suppl 3):12035.
  • 9
    Blickstein I. Does assisted reproduction technology, per se, increase the risk of preterm birth? BJOG 2006;113(Suppl 3):6972.
  • 10
    Newman RB, Goldenberg RL, Moawad AH, Iams JD, Meis PJ, Das A, et al. Occupational fatigue and preterm premature rupture of membranes. National Institute of Child Health and Human Development Maternal-Fetal Medicine, Units Network. Am J Obstet Gynecol 2001;184:43846.
  • 11
    Downey LJ, Martin AJ. Ritodrine in the treatment of preterm labour: a study of 213 patients. Br J Obstet Gynaecol 1983;90:104653.
  • 12
    Hendler I, Goldenberg RL, Mercer BM, Iams, JD, Meis PJ, Moawad AH, et al. The Preterm Prediction Study: association between maternal body mass index and spontaneous and indicated preterm birth. Am J Obstet Gynecol 2005;192:8826.
  • 13
    Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991;53:43863.
  • 14
    Facchinetti F, Fazzio M, Venturini P. Polyunsaturated fatty acids and risk of preterm delivery. Eur Rev Med Pharmacol Sci 2005;9:418.
  • 15
    Olsen SF, Secher NJ, Bjornsson S, Weber T, Atke A. The potential benefits of using fish oil in relation to preterm labor: the case for a randomised controlled trial? Acta Obstet Gynecol Scand 2003;82:97882.
  • 16
    Smits LJM, Essed GGM. Short interpregnancy intervals and unfavourable pregnancy outcome: role of folate depletion. Lancet 2001;358:20747.
  • 17
    Johnson WG, Scholl TO, Spychala JR, Buyske S, Stenroos ES, Chen X. Common dihydrofolate reductase 19-base pair deletion allele: a novel risk factor preterm delivery. Am J Clin Nutr 2005;81:6648.
  • 18
    Keirse MJNC. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol 1990;97:14951.
  • 19
    Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003;348:237985.
  • 20
    Da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomised placebo controlled double blind study. Am J Obstet Gynecol 2003;188:41924.
  • 21
    Sanchez-Ramos L, Kaunitz AM, Delke I. Progestational agents to prevent preterm birth: a meta-analysis of randomised controlled trials. Obstet Gynecol 2005;105:2739.
  • 22
    Dodd JD, Crowther CA, Cincotta R, Flenady V, Robinson JS. Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2005;84:52633.
  • 23
    Chanrachakul B, Pipkin FB, Warren AY, Arulkumaran S, Khan RN. Progesterone enhances the tocolytic effect of ritodrine in isolated pregnant human myometrium. Am J Obstet Gynecol 2005;192:45863.
  • 24
    Lamont RF. Can antibiotics prevent preterm birth—the pro and con debate? BJOG 2005;112:6773.
  • 25
    Lamont RF. Bacterial vaginosis. In: CritchleyH, ThorntonS, BennettPR, editors. Preterm Birth. Proceedings of the 46th Study Group of the Royal College of Obstetricians and Gynaecologists. London: RCOG Press; 2004. p. 16380.
  • 26
    Rosenstein IJ, Morgan DJ, Lamont RF, Sheehan M, Dore CJ, Hay PE, et al. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. Infect Dis Obstet Gynecol 2000;8:15865.
  • 27
    Lamont RF, Duncan SLB, Mandal D, Bassett P. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol 2003;101:51622.
  • 28
    Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised trial. Lancet 2003;361:9838.
  • 29
    Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ 2004;329:371.
  • 30
    Larsson P, Fåhraeus L, Carlsson B, Jakobsson T, Forsum U. Late miscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen. BJOG 2006;113:62937.